# Bharat Immunologicals & Biologicals Corporation Ltd-$ (BIBCL)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹17.38
Day Change: +0.06%
52W High: ₹28.8
52W Low: ₹14.1
Market Cap: ₹75 Cr

## Valuation
P/E: 0
P/B: 0.95
EPS: ₹-3.54
Book Value: ₹18.24
Dividend Yield: 0%

## Returns
1Y Return: -23.17%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Bharat Immunologicals & Biologicals Corporation Ltd-$ is a Biotechnology company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Biotechnology
Sub Industry: Unknown

## Business Model
Overview: Bharat Immunologicals & Biologicals Corporation Ltd-$ makes money through Technology services, Digital transformation projects, Maintenance and managed services in Biotechnology. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Technology services
- Digital transformation projects
- Maintenance and managed services
Operating Model:
- Wins client contracts, deploys skilled delivery teams, and earns project or recurring service revenue.
- Utilisation, billing rates, attrition, and currency movements are key operating levers.
Recent Context:
- Announcement: Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBI'S LODR.
- Insider Monkey: TRX Gold Corporation (TRX): 10 Best Gold Mining Stocks to Buy as Central Banks Buy Bullion
- BSE Filing: Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBI'S LODR.

## Data Freshness
Quote Updated: 2026-05-16T23:57:28.958Z
Price History Updated: 2026-05-19T01:02:33.662Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-19T01:02:33.662Z
Quant Updated: 2026-05-19T01:02:33.662Z
Sentiment Updated: 2026-05-19T01:02:33.662Z
Financials Status: stale
Financials Updated: 2026-05-18T13:30:00.909Z
Financials Last Attempt: 2026-05-18T13:30:00.909Z
Financials Provider Tried: database
Latest P&L Period: FY 2023
Latest Balance Sheet Period: FY 2023
Latest Cash Flow Period: FY 2023

## P&L (FY 2022)
Revenue: ₹78 Cr
Operating Profit: ₹-5 Cr (OPM -6.19%)
Net Profit: ₹-9 Cr
Tax: ₹-1 Cr

## Annual P&L History
FY 2022: Rev ₹78Cr | PAT ₹-9Cr | OPM -6.19%
FY 2023: Rev ₹45Cr | PAT ₹-17Cr | OPM -35.88%

## Balance Sheet (FY 2022)
Total Assets: ₹213 Cr
Total Liabilities: ₹107 Cr
Borrowings: ₹78 Cr
Cash: ₹undefined Cr

---
Source: rupiya.io/stocks/bibcl
Disclaimer: For research and education only. Not investment advice.